Myriad Genetics
In Joel Greenblatt's portfolio · Gotham Asset Management
Ticker MYGN
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Gotham Asset Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2014 | Reduce 7% | 1,117,351 | 0.5% |
| Q1 2014 | Reduce 8% | 1,206,099 | 0.6% |
| Q4 2013 | Add 36% | 1,316,314 | 0.7% |
| Q3 2013 | Add 75% | 965,987 | 0.7% |
| Q2 2013 | First 13F | 552,675 | 0.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.